Updated Data Matrix Available

Market Value | Market Volume | Epidemiology | Clinical Trials | Patent Landscape | Regulatory Approvals | COVID-19 Impact Analysis

Global Image-Guided Surgery Devices Market $7.5 Billion by 2027

The global market for image-guided surgery devices expected to cross $7.5 billion by 2027, growing at a CAGR of 7.4% over the forecast period, driven by increasing availability and rapid adoption of accurate image-guidance or surgical navigation systems for minimal invasive procedures. 

  • The rate of acceptance of these systems is quite encouraging and in the near future, it is expected that they will ultimately dictate the way most of the surgeries are performed.
Global Image-Guided Surgery Devices Market

Image-guided surgery (IGS) has made surgeries minimally invasive, thereby reducing procedure duration, complexity, and patient recovery time. Existing IGS systems use advanced tracking techniques including mechanical, optical, ultrasonic, electromagnetic, and fluorescence modalities.

  • Image guidance and localization have also enabled robotic or stereotactic surgeries. Image-guided surgical systems have revolutionized conventional surgical techniques by providing a precise treatment guidance system that can help ensure limited tissue damage, less complications. faster recovery, while maintaining the best outcome for patients.
    • For example, IGS has provided a minimally invasive alternative to complex open-heart surgeries and significantly changed the landscape for cardiac treatment (angioplasty).
  • Similarly, endoscopy has revolutionized the diagnosis and treatment of inner gastrointestinal (GI) ailments such as ulcers or tumors, eliminating the need for exploratory surgery.
    • Image-guided navigation has also simplified traditionally complicated procedures such as spinal and hip-replacement surgeries using strategically positioned sensors during surgery  to accurately determine the best placement of implants.

The global image-guided surgery devices market report provides market size ($million 2017 to 2027), market share, growth trends and forecast (CAGR%, 2021 to 2027).

The global market for image guided surgery devices segmented by product [computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET), endoscopy, single photon emission computed tomography (SPECT), ultrasound, X-ray fluoroscopy)], application [ear, nose and throat (ENT), neurosurgery, oncology, orthopedics, others], and geography.

  • Globally, the computed tomography, magnetic resonance imaging, and ultrasounds are the most commonly used devices for image-guided surgeries. The CT and X-rays are generally used for imaging bones or orthopedic defects. MRI is generally used for detecting or imaging tumors.
  • In terms of products, the computed tomography segment accounted for the largest revenue share of total IGS devices market, whereas the MRI systems segment anticipated to witness the fastest growth rate during forecast period.
    • Factors such as, introduction of innovative products, high demand for portable as well as stationary CT scanning systems, and rapid adoption of the CT scanners by various hospitals intended to be used in surgeries and post-surgery monitoring are boosting the market growth for CT-based IGS systems.
      • MRI can be performed on different body parts such as head and knee. MRI provides excellent soft tissue differentiation and spatial resolution. MRI-guided system allows a larger scanning range and provides more reliable images. Moreover, MRI can be used to identify ipsilateral axillary, supraclavicular, and parasternal lymph nodes positive for lesions with less user variability.
  • Based on applications, the neurosurgery segment where devices are used for deep brain stimulation, biopsy, and tumor resections dominated the total market for image guided surgery devices.
    • The orthopedic surgeries segment expected to be the fastest growing application segment in the coming years, attributed to innovative technologies, rapidly aging population, increasing prevalence of orthopedic diseases and higher demand for minimally invasive surgical procedures.
      • Image-guided orthopedic surgeries include knee and hip replacements, which are the primary applications for orthopedics IGS and additional applications, such as trauma and emergency interventions and ligament reconstruction. 

The global market for IGS systems research report is further divided by geography into North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), Latin America (Brazil, Mexico, Rest of LA), and Rest of the World.

  • Geographically, the North American region accounted for the largest regional market in terms of revenue, owing to increasing prevalence of chronic diseases such as cancer, cardiovascular and neurological diseases leading to utilization of minimally invasive devices such as ablation, electrosurgery and endoscopy devices.
    • In addition, the increasing number of US-FDA approvals and marketed IGS products in the region contributed to its leadership position in the market.
  • On the other hand, the Asia Pacific region poised to become the fastest growing market in the near future, due to growing elderly population, increasing number of various surgical procedures and availability of improved healthcare infrastructure in developing counties.

The global image-guided surgery products market research report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments.

Major competitors operating in the global market for image-guided surgery systems and included in this report are Abbott Laboratories, Inc., Analogic Corporation, Brainlab AG, GSI Group, Inc., Integra LifeSciences Corporation, KARL STORZ GmbH & Co. KG., Medtronic plc, Philips Healthcare (Koninklijke Philips N.V.), Siemens Healthineers AG (Varian Medical Systems, Inc.), Smith & Nephew plc, Toshiba Corporation, and Zimmer Biomet Holdings, Inc.

  • Product
    • Computed Tomography (CT)
    • Magnetic Resonance Imaging (MRI)
    • Positron Emission Tomography (PET)
    • Single Photon Emission Computed Tomography (SPECT)
    • Endoscopy
    • Ultrasound
    • X-ray Fluoroscopy
  • Application
    • Ear, Nose and Throat (ENT) Surgery
    • Neurosurgery
    • Oncology Surgery
    • Orthopedic Surgery
    • Others Surgeries
  • Geography (Region, Country)
    • North America (U.S., Canada)
    • Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    • Asia Pacific (Japan, China, India, Rest of APAC)
    • Latin America (Brazil, Mexico, Rest of LA)
    • Rest of the World
  • Company Profiles
    • Abbott Laboratories, Inc.
    • Analogic Corporation
    • Brainlab AG
    • GSI Group, Inc.
    • Integra LifeSciences Corporation
    • KARL STORZ GmbH & Co. KG.
    • Medtronic plc
    • Philips Healthcare (Koninklijke Philips N.V.)
    • Siemens Healthineers AG (Varian Medical Systems, Inc.)
    • Smith & Nephew plc
    • Toshiba Corporation
    • Zimmer Biomet Holdings, Inc.

To request Table of Contents and Sample Pages of this report visit:

Related publications:

    Request ToC/Sample information for this market analysis

    Full Name*

    Company Email*

    Phone Number* [Please add country code]



    Secure Online Payment

    iHealthcareAnalyst, Inc.

    Contact Address

    US Office: 2109, Mckelvey Hill Drive, Maryland Heights, MO 63043, United States
    Phone: +1 (314) 315-4764
    India Office: 5, Shilpa Chambers, Opp. J. M. Road, Shivajinager, Pune 411005, India
    Phone: +91 (20) 25898524
    Email: [email protected]